When considering the relevance of 15-PGDH and COX-2 to neovascularization, the present study found that the low 15-PGDH and high COX-2 expression levels were associated with an unfavorable prognosis in the NSCLC patients. This evidence concerns the gene HPGD and non-small cell lung carcinoma.